TONIX PHARMACEUTICALS HOLDING CORP. (NASDAQ:TNXP) Files An 8-K Regulation FD DisclosureItem 7.01
Tonix Pharmaceuticals Holding Corp. the “Company”) updated its investor presentations, which are used to conduct meetings with investors, stockholders and analysts and at investor conferences, and which the Company intends to place on its website, which may contain nonpublic information. Copies of the investor presentations are filed as Exhibits 99.01, 99.02 and 99.03, and incorporated by reference in, this report.
| Item 9.01 | Financial Statements and Exhibits. |
Tonix Pharmaceuticals Holding Corp. ExhibitEX-99.01 2 s114302_ex99-01.htm EXHIBIT 99.01 Exhibit 99.01 © 2018 Tonix Pharmaceuticals Holding Corp. November 2018 Version P0149 11 – 30 – 18 (Doc 0420) Investor Presentation © 2018 Tonix Pharmaceuticals Holding Corp. 2 Cautionary Note on Forward – Looking Statements Certain statements in this presentation regarding strategic plans,…To view the full exhibit click here
